Chelsea Caspell‐Garcia

Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study

Andrew Siderowf, Luis Concha‐Marambio, David-Erick Lafontant et al. · The Lancet Neurology · 2023 · 693 citations · Full text

Life Sciences, Neurology, Neuroscience +14

The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

Kenneth Marek, Sohini Chowdhury, Andrew Siderowf et al. · Annals of Clinical and Translational Neurology · 2018 · 686 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

Daniel Weintraub, Tanya Simuni, Chelsea Caspell‐Garcia et al. · Movement Disorders · 2015 · 307 citations · Full text

Medicine, Neurology, Psychiatry +17

High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease

Marco J. Russo, Christina D. Orrú, Luis Concha‐Marambio et al. · Acta Neuropathologica Communications · 2021 · 259 citations · Full text

Life Sciences, Neurology, Neuroscience +17

CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study

Ju‐Hee Kang, Brit Mollenhauer, Christopher S. Coffey et al. · Acta Neuropathologica · 2016 · 222 citations · Full text

Life Sciences, Neurology, Neuroscience +17